U.S. Acurion Completes $4.3M Seed Round and Expands Team
Acurion has expanded its leadership team, board of directors, and advisory team following the recent...
U.S. FDA Approves Roche's PTEN Test for Companion Diagnosis in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has approved the VENTANA PTEN (SP218) RxDx assay for mar...
China's MGI Launches Partner Program at ESHG 2026, 27 T7+ Units Installed
MGI Tech Co., Ltd. (MGI) showcased its latest advancements in sequencing, automation, and clinical g...
Japanese Team Develops Nanowire Device for Rapid, Non-Invasive Cancer Detection
A research team from Nagoya University, Hokkaido University, Tokyo University of Science, Kyoto Univ...
U.S. Pneumonia Treatment Market Continues to Expand, Leading Global Share in 2025
The pneumonia treatment market is experiencing sustained expansion, primarily driven by an aging pop...
Roche Develops PCR Test for Bundibugyo Virus in Six Days
Roche has announced the rapid development of a research-use-only (RUO) molecular polymerase chain re...
U.S. Bluejay Diagnostics Completes $8.5 Million Private Placement
Bluejay Diagnostics announced the completion of a private placement, raising total gross proceeds of...
QuantiPath Adds Dr. Stephens to Expand Food Safety Team
Denver-based biotechnology company QuantiPath announced on June 3, 2026, that Dr. Tyler Stephens has...
Australia's Lumos FebriDx Commercialized Across Over 100 Institutions in 18 U.S. States
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has achieved initial progress in the U.S. commer...
UK study shows genetic testing could spare over 5,000 breast cancer patients from chemotherapy
A major international clinical trial led by University College London (UCL) has found that genetic t...